Study Summaries

GOG 174: Weekly Methotrexate vs. Pulsed Dactinomycin for Low-Risk GTN

Trastuzumab in HER2-Positive Uterine Serous Carcinoma (Fader)

ICON4/AGO-OVAR-2.2: Paclitaxel–Platinum vs Platinum in Platinum-Sensitive Relapsed Ovarian Cancer

SORAYA: Mirvetuximab Soravtansine in FRα-High Platinum-Resistant Ovarian Cancer

GOG 85: Cisplatin/5-FU vs Hydroxyurea with Radiation in Locally Advanced Cervical Cancer

GOG 161: Ifosfamide ± Paclitaxel in Advanced Uterine Carcinosarcoma

ASTEC: Pelvic Lymphadenectomy in Endometrial Cancer

GOG 182/ICON5: Five-Arm First-Line Trial in Advanced Ovarian Cancer

ICON3: Paclitaxel–Carboplatin vs Carboplatin or CAP in First-Line Ovarian Cancer

GOG 157: Three vs Six Cycles of Carboplatin–Paclitaxel in Early-Stage Ovarian Cancer